Testing effectiveness (Phase 2)UnknownNCT04433845
What this trial is testing
The Safety and Efficacy of Psilocybin in Participants With Type 2 Bipolar Disorder (BP-II) Depression.
Who this might be right for
Treatment Resistant Depression
Sheppard Pratt Health System 15